Skip to main content

Table 2 Demographic and clinical characteristics of the patients with and without recurrence

From: Factors predicting recurrence after curative resection for rectal cancer: a 16-year study

 

Without recurrence, n = 135

Recurrence, n = 53

Total, N = 188

N

%

N

%

N

%

Demographic characteristics

 Sex

  Male

84

62.2

24

45.3

108

57.4

  Female

51

37.8

29

54.7

80

42.6

 Age

  < 50 years

23

17.0

18

34.0

41

21.8

  ≤ 50 years

112

83.0

35

66.0

147

78.2

Clinical characteristics

 Location of the tumor

  Upper rectum

36

26.7

9

17.0

45

23.9

  Middle rectum

49

36.3

16

30.2

65

34.6

  Low rectum

50

37.0

28

50.9

77

41.0

 Size of the tumor

  < 5 cm

92

68.1

24

45.2

116

61.7

  > 5 cm

43

31.1

29

54.8

72

38,3

 Stenotic character

  Yes

21

15

13

24.6

34

18

  No

114

85

40

75.4

154

82

 CEA levels

  Normal

26

19.2

24

45.2

50

27

  Abnormal

109

80.8

29

54.8

138

73

 Neoadjuvant therapy

  Yes

85

62.9

35

66

120

63.8

  No

50

37.1

18

34

68

36.2

 Surgical intervention

  Abdominoperineal resection

22

15.6

13

24.5

35

18.1

  Anterior resection of the rectum

108

70.4

36

67.9

144

77.1

  Local excision

5

4.4

4

7.5

9

4.8

 Distal margin

  ≤ 2 cm

37

27.4

31

58.4

68

37

  > 2 cm

90

72.6

22

41.6

112

63

 Intraoperative incident

  Yes

32

23.7

17

32

49

26

  No

103

76.3

36

68

139

64

 pT stage

  T1–T2

54

40

10

18.8

64

34

  T3–T4

81

60

43

81.2

124

66

 Invasion of neighboring organs

  Yes

6

4

10

18.8

16

8.5

  No

129

96

43

81.2

172

11.5

 Tumor perforation

  Yes

2

1.5

5

9.4

7

3.7

  No

133

98.5

48

90.6

181

96.3

 pN stage

  N0

106

78.5

21

39.6

127

67.5

  N+

29

21.5

32

60.4

61

32.5

 Extra capsular invasion

  Yes

8

6

31

58.4

39

20.7

  No

127

64

22

41.6

149

79.3

 Vascular emboli

  Yes

10

7.4

20

37.7

30

16

  No

125

92.6

33

62.3

158

84

 Lymphatic and perineural invasion

  Yes

7

5.2

14

26.4

21

11.1

  No

128

94.8

39

73.6

167

88.9

 pTNM stage

  I and II

102

75.5

22

41.5

124

66

  III and IV

33

84.5

31

58.5

64

34